IHI Prominent
@IHI_PROMINENT
Followers
140
Following
891
Media
65
Statuses
238
This project has received funding from the Innovative Health Initiative Joint Undertaking (JU) under grant agreement No 101112145. https://t.co/s2dj67Hojx
Stockholm, Sweden
Joined March 2023
RT @AlzheimerEurope: Partners from the @IHI_PROMINENT project present at #AAIC25 in Toronto.#AEScienceWatch .
alzheimer-europe.org
On 27 to 31 July, PROMINENT partners presented new work at the Alzheimer’s Association International Conference (AAIC) 2025 in Toronto, Canada.
0
1
0
#AAIC25 continues!.Don't miss Sophie van der Landen (Alzheimer Center Amsterdam) who presents Poster #105648 test-retest reliability of web-based cognitive assessment cCOG, part of @IHIEurope's @ihi_prominent & @AD_RIDDLE projects. 🗓️ Wednesday 30 July (breaks)
0
2
2
RT @AlzheimerEurope: Alzheimer Europe welcomes CHMP positive opinion on donanemab for treatment of early #Alzheimers disease, following re-….
0
8
0
#AAIC25 update 🌟.Lena Sannemann discussed the @IHIEurope funded @IHI_PROMINENT project on evaluating & validating a precision medicine platform in neurodegenerative disease. Alina Solomon spoke about the use of (digital) biomarkers to monitor disease progression. 🦾to #ENDalz
0
0
1
#AAIC25 kicks off soon! .Catch Lena Sannemann (University of Cologne) presenting Poster #640: Evaluation & Validation of a Precision Medicine Platform in Neurodegenerative Disease @IHIEurope's @IHI_PROMINENT.🗓️ Join on Sunday 27 July at 12:15 & 14:00! .
4
0
2
RT @SynapseManagers: Today is #WorldBrainDay 🧠. A global initiative to raise awareness of the importance of safeguarding brain health. At S….
0
2
0
🧠Today on #WorldBrainDay #WBD2025, we highlight the @IHIEurope funded @ihi_prominent project, creating a digital platform for precision medicine in Alzheimer’s disease. 🔗
0
1
0
RT @AD_RIDDLE: New @IHIEurope article, featuring an interview with Linus Jönsson on how the @IHI_PROMINENT and @AD_RIDDLE projects are usin….
ihi.europa.eu
PROMINENT and AD-RIDDLE, two projects focusing on Alzheimer’s disease, are channelling health economics to ensure that new therapies and diagnostic methods for Alzheimer’s disease can be effectively...
0
2
0
Want to know more? .Check out our spotlight on early career researchers interview with first author Xin Xia:
0
1
1
What are the predictive objectives, constituting predictors and algorithms, as well as the performance of existing multimodal prediction models for Alzheimer's disease?. Have a read of our latest scoping review funded through @ihieurope:
journals.sagepub.com
Background Multimodal prediction models for Alzheimer's disease (AD) are emerging as promising tools for improving detection and informing prognosis. Obje...
1
2
2
RT @ChrisBintener: Exciting days ahead for the @adis_jpnd symposium at @fraunhofer_scai. Looking forward to @IHI_PROMINENT, @AD_RIDDLE & @p….
0
2
0
The @ihieurope funded @ihi_PROMINENT Newsletter #4 is out now. Highlights 🌟EU authorises lecanemab for early Alzheimer’s, clinician survey on decision support, latest biomarker research & @AlzheimerEurope European Parliament debate. Read & subscribe:
2
2
5
RT @AlzheimerEurope: A huge thank you to our hosts, speakers and guests at today's #AELunchDebate in Brussels. Great presentations and disc….
0
4
0
RT @AlzheimerEurope: Our European Parliament lunch debate today focused on preparing for new Alzheimer’s treatments in Europe. Thank you to….
0
7
0
📢IHI-PROMINENT is at the #EuropeanParliament ! 🇪🇺. At the AE lunch debate on “Preparing for new Alzheimer’s treatments in Europe”, Linus Jönsson, co-lead of PROMINENT, talks about precision medicine in neurodegenerative disorders. 🧠#Alzheimers #dementia #digitalhealth
4
1
3
RT @AlzheimerEurope: Our second speaker at this European Parliament Lunch Debate is Linus Jönsson from @karolinskainst. He is discussing "P….
0
2
0
Makrina Daniilidou presented findings at #ADPD2025, explaining how comorbidities affect the reliability of blood-based biomarkers for Alzheimer’s diagnosis. We spoke with her about the implications for clinical use. Read the interview:
0
2
2
RT @AlzheimerEurope: With #lecanemabauthorised in the EU, the @IHIeurope @IHI_PROMINENT project s helping address challenges in diagnosis,….
0
3
0
Have a read of the latest @AlzheimerEurope newsletter featuring an article on clinicians' perspectives on clinical decision support systems for Alzheimer’s disease, research conducted as part of the @IHI_PROMINENT project ⤵️.
Check out our March 2025 newsletter! It includes updates on the European Alzheimer's Alliance, our upcoming Annual Conference in Bologna #35AEC, the disappointing negative opinion of the European Medicines Agency on donanemab, and much more. Read it here:
0
0
3
RT @AlzheimerEurope: Earlier today, Eisai and Biogen announced that the European Commission has decided to refer the marketing authorisatio….
0
2
0